Holers VM - Search Results

1

Pickering MC, D'Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT. Pickering MC, et al. Among authors: holers vm. Kidney Int. 2013 Dec;84(6):1079-89. doi: 10.1038/ki.2013.377. Epub 2013 Oct 30. Kidney Int. 2013. PMID: 24172683 Free PMC article.

2

Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.

Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Thurman JM, et al. Among authors: holers vm. J Immunol. 2003 Feb 1;170(3):1517-23. doi: 10.4049/jimmunol.170.3.1517. J Immunol. 2003. PMID: 12538716

3

Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis.

Mühlfeld AS, Segerer S, Hudkins K, Farr AG, Bao L, Kraus D, Holers VM, Quigg RJ, Alpers CE. Mühlfeld AS, et al. Among authors: holers vm. Kidney Int. 2004 Apr;65(4):1214-23. doi: 10.1111/j.1523-1755.2004.00495.x. Kidney Int. 2004. PMID: 15086460 Free article.

4

The alternative pathway of complement in disease: opportunities for therapeutic targeting.

Holers VM, Thurman JM. Holers VM, et al. Mol Immunol. 2004 Jun;41(2-3):147-52. doi: 10.1016/j.molimm.2004.03.012. Mol Immunol. 2004. PMID: 15159060 Review.

5

Acute tubular necrosis is characterized by activation of the alternative pathway of complement.

Thurman JM, Lucia MS, Ljubanovic D, Holers VM. Thurman JM, et al. Among authors: holers vm. Kidney Int. 2005 Feb;67(2):524-30. doi: 10.1111/j.1523-1755.2005.67109.x. Kidney Int. 2005. PMID: 15673300 Free article.

6

The central role of the alternative complement pathway in human disease.

Thurman JM, Holers VM. Thurman JM, et al. Among authors: holers vm. J Immunol. 2006 Feb 1;176(3):1305-10. doi: 10.4049/jimmunol.176.3.1305. J Immunol. 2006. PMID: 16424154 Review.

7

Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.

Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM. Banda NK, et al. Among authors: holers vm. J Immunol. 2006 Aug 1;177(3):1904-12. doi: 10.4049/jimmunol.177.3.1904. J Immunol. 2006. PMID: 16849503

8

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.

Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Girardi G, et al. Among authors: holers vm. J Exp Med. 2006 Sep 4;203(9):2165-75. doi: 10.1084/jem.20061022. Epub 2006 Aug 21. J Exp Med. 2006. PMID: 16923853 Free PMC article.

9

Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.

Clark A, Weymann A, Hartman E, Turmelle Y, Carroll M, Thurman JM, Holers VM, Hourcade DE, Rudnick DA. Clark A, et al. Among authors: holers vm. Mol Immunol. 2008 Jun;45(11):3125-32. doi: 10.1016/j.molimm.2008.03.008. Epub 2008 May 1. Mol Immunol. 2008. PMID: 18452991 Free PMC article.

10

Aseptic injury to epithelial cells alters cell surface complement regulation in a tissue specific fashion.

Thurman JM, Renner B, Kunchithapautham K, Holers VM, Rohrer B. Thurman JM, et al. Among authors: holers vm. Adv Exp Med Biol. 2010;664:151-8. doi: 10.1007/978-1-4419-1399-9_18. Adv Exp Med Biol. 2010. PMID: 20238013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters